Filter
455
Filtered Results: 455
Text search:
chlamydia
Featured
Recommendations
51
New Publications
131
Language
Document type
No document type
283
Guidelines
82
Studies & Reports
37
Manuals
19
Fact sheets
12
Strategic & Response Plan
8
Training Material
6
Brochures
4
Infographics
3
Situation Updates
1
Countries / Regions
India
15
South Africa
14
Nepal
13
Global
13
Tanzania
11
Philippines
9
Germany
9
Kenya
8
Rwanda
8
Ukraine
7
Nigeria
7
Africa
7
Western and Central Europe
7
Cameroon
5
Congo, Democratic Republic of
5
Paraguay
5
Argentina
5
Russia
5
Namibia
5
Indonesia
5
Lesotho
4
Uganda
4
Brazil
4
Ethiopia
4
Zambia
4
Senegal
3
Zimbabwe
3
Asia
3
Latin America and the Carribbean
3
Bangladesh
3
Switzerland
2
Ghana
2
Benin
2
Sierra Leone
2
Togo
2
Peru
2
Mozambique
2
Eastern Europe
2
Central African Republic
2
Botswana
2
Liberia
2
Myanmar / Burma
2
Madagascar
2
Eswatini/ Swaziland
2
Colombia
1
Chile
1
Syria
1
Albania
1
Burkina Faso
1
Malawi
1
Haiti
1
Cambodia
1
Turkmenistan
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Yemen
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
166
Women & Child Health
55
Clinical Guidelines
51
Public Health
17
Capacity Building
15
Key Resources
5
Pharmacy & Technologies
5
Toolboxes
HIV
84
Refugee
25
AMR
23
NTDs
22
Pharmacy
14
TB
12
COVID-19
10
Rapid Response
9
Caregiver
9
Conflict
7
Disability
5
Mental Health
4
NCDs
4
Planetary Health
3
Global Health Education
3
Ebola
2
Zika
2
Specific Hazards
1
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi...
Module 2
Community Educators and Advocates
July 2017
Module 2: Community educators and advocates. Community educators and advocates are needed to increase awareness about PrEP in their communities. This module provides information on PrEP that should be considered in community-led activities ...
Module 4
Leaders
July 2017
Module 4: Leaders. This module aims to inform and update leaders and decision-makers about PrEP. It provides information on the benefits and limitations of PrEP so that they can consider how PrEP could be effectively implemented in their own settings. It also contai...
Module 10
Testing providers
July 2017
Module 10: Testing providers. This module is for people who provide testing services at PrEP sites and laboratories. It offers guidance in selecting testing services, including screening of individuals before PrEP is initiated and monitoring while they ar...
Module 12:
Adolescents and young adults
July 2018
Module 12: Adolescents and young adults. This module is for people who are interested in providing PrEP services to older adolescents and young adults who are at substantial risk for HIV. It provides information on: factors that influence HIV...
Module 1q
PrEP users
July 2017
Module 11: PrEP users. This module provides information for people who are interested in taking PrEP to reduce their risk of acquiring HIV and people who are already taking PrEP – to support them in their choice and use of PrEP. This module gives ideas for cou...
Accessed: 03.03.2020
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing document. It is an overview of the different activities ...
2018
9th Edition
Offering information on HIV/AIDS treatment, prevention, and research
Participant Manual September 2012
Surveillance of Populations at High Risk for HIV Transmission
Version 9.0
Octobre 2017
Nosocomial infections and antimicrobial resistance are two special health issues listed in Annex 1 of Commission Decision 2000/96/EC of 22 December 1999 on the communicable diseases to be progressively covered by the Community network under Decision No 2119/98/EC of the European Parliament and of th...
The guidelines are to be used to guide the management of adults with lower respiratory tract infection (LRTI). As will be seen in the following text, this diagnosis, and the other clinical syndromes within this grouping, can be difficult to make accurately. In the absence of agreed definitions of th...
The international community sits at the tipping pointof a post-‐antibiotic era, where common bacterial infections are no longer treatable with the antibiotic armamentarium that exists. In South Africa, t...
The product of all this work is the Standard Treatment Guideline and Essential Medicines List of Common Medical Conditions in the Kingdom of Swaziland. These systematically developed statements are designed to assist practitioners in making decisions about appropriate treatment for specific clinical...
Internationally, there is a growing concern over antimicro-bial resistance (AMR) which is currently estimated to ac-count for more than 700,000 deaths per year worldwide. If no appropriate measures are taken to halt its pro-gress, AMR will cost approximately 10 million lives andabout US$100 trillion...
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the ...
